Trial
NCT01248130
Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Autism Spectrum Disorder (ASD)
Intervention
Omega-3 Fatty Acid
Why stopped
Due to a change in the research priorities of the principal investigator in combination with low subject interest.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-27